4//SEC Filing
ACELRX PHARMACEUTICALS INC 4
Accession 0001104659-14-018559
$TLPHCIK 0001427925operating
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 8:29 PM ET
Size
10.2 KB
Accession
0001104659-14-018559
Insider Transaction Report
Form 4
Transactions
- Other
Common Stock
2014-03-07−1,300,000→ 2,871,933 total(indirect: See footnote)
Footnotes (2)
- [F1]Represents a pro-rata in-kind distribution by Skyline Venture Partners Qualified Purchaser Fund IV, L.P. ("SVP IV") without consideration to its limited and general partners.
- [F2]The shares are held by SVP IV. John G. Freund, M.D. and Yasunori Kaneko, M.D. are the Managing Members of Skyline Venture Management IV, LLC, the general partner of SVP IV, and may be deemed to share voting and dispositive power over the shares held by SVP IV. Stephen Hoffman, M.D., Ph.D., one of the Issuer's directors, is a member of Skyline Venture Management IV, LLC and may be deemed to share voting and dispositive power with respect to the shares of Common Stock held by SVP IV. Each of Drs. Freund and Kaneko disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. Stephen Hoffman is a director of the Issuer and, accordingly, files separate Section 16 reports.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001427925
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 8:29 PM ET
- Size
- 10.2 KB